BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1359964)

  • 1. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus.
    Kwok RP; Cameron JL; Faller DV; Fernstrom JD
    Endocrinology; 1992 Dec; 131(6):2999-3009. PubMed ID: 1359964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cysteamine administration on the in vivo incorporation of [35S]cysteine into somatostatin-14, somatostatin-28, arginine vasopressin, and oxytocin in rat hypothalamus.
    Cameron JL; Fernstrom JD
    Endocrinology; 1986 Sep; 119(3):1292-7. PubMed ID: 2874017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cysteamine injection on vasopressin and oxytocin biosynthesis in rat hypothalamus.
    Kwok RP; Cameron JL; Fernstrom JD
    Neuroendocrinology; 1994 Mar; 59(3):218-27. PubMed ID: 8159271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies of somatostatin-14 and somatostatin-28 biosynthesis in rat hypothalamus.
    Van Itallie CM; Fernstrom JD
    Endocrinology; 1983 Oct; 113(4):1210-7. PubMed ID: 6137359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of cysteamine as a tool to deplete somatostatin in the rat central nervous system.
    Cook LL; Bissette G; Dole K; Nemeroff CB
    Endocrinology; 1989 Feb; 124(2):855-61. PubMed ID: 2563244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo biosynthesis of arginine vasopressin and oxytocin in hypothalami from intact and hypophysectomized rats.
    Wetsel WC; Fernstrom JD
    Endocrinology; 1987 Jun; 120(6):2562-8. PubMed ID: 2883002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of food deprivation in the rat on hypothalamic expression of growth hormone-releasing factor and somatostatin.
    Bruno JF; Olchovsky D; White JD; Leidy JW; Song J; Berelowitz M
    Endocrinology; 1990 Nov; 127(5):2111-6. PubMed ID: 1977579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.
    Srikant CB; Patel YC
    Endocrinology; 1984 Sep; 115(3):990-5. PubMed ID: 6146517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteamine-induced depletion of somatostatin in sheep: time course of depletion and changes in plasma metabolites, insulin, and growth hormone.
    McLeod KR; Harmon DL; Schillo KK; Mitchell GE
    J Anim Sci; 1995 Jan; 73(1):77-87. PubMed ID: 7601757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat.
    Millard WJ; Sagar SM; Badger TM; Carr DB; Arnold MA; Spindel E; Kasting NW; Martin JB
    Endocrinology; 1983 Feb; 112(2):518-25. PubMed ID: 6184215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of cysteamine on cognitive and locomotor behavior in rats: relationship to hippocampal glial pathology and somatostatin levels.
    Justino L; Welner SA; Tannenbaum GS; Schipper HM
    Brain Res; 1997 Jun; 761(1):127-34. PubMed ID: 9247075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteamine-induced depletion of somatostatin and prolactin.
    Millard WJ; Sagar SM; Martin JB
    Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin in rat tissues is depleted by cysteamine administration.
    Szabo S; Reichlin S
    Endocrinology; 1981 Dec; 109(6):2255-7. PubMed ID: 6118261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-induced somatostatin release from perifused rat hypothalamus: calcium dependency and effect of cysteamine treatment.
    Shimatsu A; Kato Y; Matsushita N; Ohta H; Kabayama Y; Imura H
    Neurosci Lett; 1983 Jun; 37(3):285-9. PubMed ID: 6136940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypophysectomy on somatostatin-14 and somatostatin-28 biosynthesis in the rat hypothalamus.
    Wetsel WC; Fernstrom JD
    Brain Res; 1986 Apr; 370(2):315-20. PubMed ID: 2871892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo somatostatin, vasopressin, and oxytocin synthesis in diabetic rat hypothalamus.
    Fernstrom JD; Fernstrom MH; Kwok RP
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E661-6. PubMed ID: 1970706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine.
    Sagar SM; Landry D; Millard WJ; Badger TM; Arnold MA; Martin JB
    J Neurosci; 1982 Feb; 2(2):225-31. PubMed ID: 6121016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of somatostatin synthesis by GABAA receptor stimulation in mouse brain.
    Llorens-cortes C; Bertherat J; Jomary C; Kordon C; Epelbaum J
    Brain Res Mol Brain Res; 1992 May; 13(4):277-81. PubMed ID: 1352611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteamine can induce duodenal ulceration in rats without depletion of immunoreactive somatostatin.
    Kapuscinski M; Shulkes A; Green M; Read D; MacLellan DG
    Regul Pept; 1991 Nov; 36(3):391-406. PubMed ID: 1687422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.